Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Greenwich LifeSciences, Inc.
Goto 0, 1, 2, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-03-15
Purchase
2023-03-16
06:05 am
Greenwich LifeSciences Inc.GLSIThompson Jaye
VP Clinical Reg Affairs
250$12.71$3,178257,745
(Direct)
View
2023-03-10
Purchase
2023-03-13
07:15 am
Greenwich LifeSciences Inc.GLSIPatel Snehal
CEO and CFO
10% Owner
1,000$12.12$12,1202,737,486
(Direct)
View
2023-02-24
Purchase
2023-02-28
06:03 am
Greenwich LifeSciences Inc.GLSIThompson Jaye
VP Clinical Reg Affairs
250$15.39$3,849257,495
(Direct)
View
2023-02-17
Purchase
2023-02-22
06:07 am
Greenwich LifeSciences Inc.GLSIPatel Snehal
CEO and CFO
10% Owner
600$16.53$9,9182,736,486
(Direct)
View
2023-02-10
Purchase
2023-02-14
06:08 am
Greenwich LifeSciences Inc.GLSIPatel Snehal
CEO and CFO
10% Owner
1,000$18.68$18,6802,735,886
(Direct)
View
2023-02-03
Purchase
2023-02-07
06:10 am
Greenwich LifeSciences Inc.GLSIThompson Jaye
VP Clinical Reg Affairs
250$20.84$5,210257,245
(Direct)
View
2023-01-27
Purchase
2023-01-31
06:15 am
Greenwich LifeSciences Inc.GLSIPatel Snehal
CEO and CFO
10% Owner
2,000$19.35$38,7002,734,886
(Direct)
View
2023-01-27
Purchase
2023-01-30
06:15 am
Greenwich LifeSciences Inc.GLSIThompson Jaye
VP Clinical Reg Affairs
250$19.2$4,800256,995
(Direct)
View
2023-01-20
Purchase
2023-01-24
06:05 am
Greenwich LifeSciences Inc.GLSIPatel Snehal
CEO and CFO
10% Owner
1,500$17.37$26,0552,732,886
(Direct)
View
2023-01-13
Purchase
2023-01-17
06:02 am
Greenwich LifeSciences Inc.GLSIThompson Jaye
VP Clinical Reg Affairs
250$16.5$4,125256,745
(Direct)
View
2023-01-06
Purchase
2023-01-10
06:05 am
Greenwich LifeSciences Inc.GLSIPatel Snehal
CEO and CFO
10% Owner
1,500$15.18$22,7702,731,386
(Direct)
View
2022-12-29
Purchase
2023-01-03
06:05 am
Greenwich LifeSciences Inc.GLSIPatel Snehal
CEO and CFO
10% Owner
4,000$15.19$60,7602,729,886
(Direct)
View
2022-12-16
Purchase
2022-12-20
06:05 am
Greenwich LifeSciences Inc.GLSIPatel Snehal
CEO and CFO
10% Owner
1,000$13.01$13,0102,725,886
(Direct)
View
2022-12-16
Purchase
2022-12-20
06:05 am
Greenwich LifeSciences Inc.GLSIThompson Jaye
VP Clinical Reg Affairs
250$12.94$3,235256,495
(Direct)
View
2022-12-09
Purchase
2022-12-13
06:05 am
Greenwich LifeSciences Inc.GLSIPatel Snehal
CEO and CFO
10% Owner
2,000$13.11$26,2202,724,886
(Direct)
View
2022-12-02
Purchase
2022-12-06
06:15 am
Greenwich LifeSciences Inc.GLSIPatel Snehal
CEO and CFO
10% Owner
1,000$13.84$13,8402,722,886
(Direct)
View
2022-12-02
Purchase
2022-12-06
06:15 am
Greenwich LifeSciences Inc.GLSIThompson Jaye
VP Clinical Reg Affairs
250$13.98$3,495256,245
(Direct)
View
2022-11-02
Purchase
2022-11-04
06:15 am
Greenwich LifeSciences Inc.GLSIPatel Snehal
CEO and CFO
10% Owner
2,000$8.79$17,5802,721,886
(Direct)
View
2022-10-14
Purchase
2022-10-17
07:00 am
Greenwich LifeSciences Inc.GLSIPatel Snehal
CEO and CFO
10% Owner
3,000$9.75$29,2502,719,886
(Direct)
View
2022-10-07
Purchase
2022-10-11
06:05 am
Greenwich LifeSciences Inc.GLSIPatel Snehal
CEO and CFO
10% Owner
2,000$9.72$19,4402,716,886
(Direct)
View
2022-09-30
Purchase
2022-10-04
06:05 am
Greenwich LifeSciences Inc.GLSIPatel Snehal
CEO and CFO
10% Owner
1,000$9.46$9,4602,714,886
(Direct)
View
2022-09-29
Purchase
2022-10-03
06:15 am
Greenwich LifeSciences Inc.GLSIPatel Snehal
CEO and CFO
10% Owner
1,000$9.23$9,2302,713,886
(Direct)
View
2022-06-24
Purchase
2022-06-27
06:05 am
Greenwich LifeSciences Inc.GLSIPatel Snehal
CEO and CFO
10% Owner
29,000$9.13$264,7705,419,307
(Indirect
Direct)
View
2022-06-16
Purchase
2022-06-17
06:05 am
Greenwich LifeSciences Inc.GLSIPatel Snehal
CEO and CFO
10% Owner
8,000$7.13$57,0402,683,886
(Direct)
View
2022-06-14
Purchase
2022-06-15
06:05 am
Greenwich LifeSciences Inc.GLSIPatel Snehal
CEO and CFO
10% Owner
12,000$7.91$94,9202,675,886
(Direct)
View
2022-06-10
Purchase
2022-06-13
06:04 am
Greenwich LifeSciences Inc.GLSIPatel Snehal
CEO and CFO
10% Owner
12,000$8.33$99,9602,663,886
(Direct)
View
2022-06-09
Purchase
2022-06-10
06:05 am
Greenwich LifeSciences Inc.GLSIPatel Snehal
CEO and CFO
10% Owner
4,500$10.9$49,0501,243,453
(Direct)
View
2022-06-07
Purchase
2022-06-08
06:07 am
Greenwich LifeSciences Inc.GLSIPatel Snehal
CEO and CFO
10% Owner
6,000$8.55$51,3001,238,953
(Direct)
View
2022-06-03
Purchase
2022-06-06
06:05 am
Greenwich LifeSciences Inc.GLSIPatel Snehal
CEO and CFO
10% Owner
9,250$8.35$77,2381,232,953
(Direct)
View
2022-06-02
Purchase
2022-06-03
06:05 am
Greenwich LifeSciences Inc.GLSIPatel Snehal
CEO and CFO
10% Owner
6,774$7.38$49,9921,223,703
(Direct)
View
2022-04-25
Purchase
2022-04-26
06:05 am
Greenwich LifeSciences Inc.GLSIDaugherty Frank Joseph
Chief Medical Officer
1,000$16.25$16,25090,121
(Direct)
View
2022-04-21
Purchase
2022-04-22
06:04 am
Greenwich LifeSciences Inc.GLSIPatel Snehal
CEO and CFO
10% Owner
6,000$16.09$96,5401,216,929
(Direct)
View
2022-04-19
Purchase
2022-04-21
06:03 am
Greenwich LifeSciences Inc.GLSIPatel Snehal
CEO and CFO
10% Owner
6,000$16.74$100,4401,210,929
(Direct)
View
2022-04-19
Purchase
2022-04-20
06:02 am
Greenwich LifeSciences Inc.GLSIThompson Jaye
VP Clinical Reg Affairs
500$16.74$8,370255,995
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-06-22
Option Award
2022-06-24
08:18 am
N/A
2032-06-22
Greenwich LifeSciences Inc.GLSIDaugherty Frank Joseph
Chief Medical Officer
104,890$0104,890
(Direct)
View
2022-06-22
Option Award
2022-06-24
08:16 am
N/A
2032-06-22
Greenwich LifeSciences Inc.GLSIPatel Snehal
CEO and CFO
10% Owner
1,073,731$02,122,454
(Direct)
View
2022-06-22
Option Award
2022-06-24
08:14 am
N/A
2032-06-22
Greenwich LifeSciences Inc.GLSIThompson Jaye
VP Clinical Reg Affairs
149,818$0149,818
(Direct)
View
2022-06-22
Option Award
2022-06-24
08:12 am
N/A
2032-06-22
Greenwich LifeSciences Inc.GLSIHallock Kenneth
Director
41,349$041,349
(Direct)
View
2022-06-22
Option Award
2022-06-24
08:11 am
N/A
2032-06-22
Greenwich LifeSciences Inc.GLSIRothe Eric
Director
41,349$041,349
(Direct)
View
2022-06-22
Option Award
2022-06-24
08:10 am
N/A
2032-06-22
Greenwich LifeSciences Inc.GLSIMcWilliams David
Director
61,984$061,984
(Direct)
View
Goto 0, 1, 2, Next